Atrys Health SA
F:A2T
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Atrys Health SA
F:A2T
|
ES |
|
CapMan Oyj
F:AP6
|
FI |
|
Avolta AG
F:D2JA
|
CH |
|
P
|
Perdoceo Education Corp
F:CE1
|
US |
|
T
|
Tyler Technologies Inc
F:TYP
|
US |
|
D
|
Dai Nippon Printing Co Ltd
F:DNP
|
JP |
|
P
|
Perdoceo Education Corp
XMUN:CE1
|
US |
|
C
|
Coca-Cola Co
XMUN:CCC3
|
US |
|
Kitron ASA
OSE:KIT
|
NO |
|
A
|
Abercrombie & Fitch Co
XMUN:AFT
|
US |
Intrinsic Value
Is A2T undervalued or overvalued?
See the intrinsic value estimate for Atrys Health SA and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
A2T looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with A2T’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Atrys Health Does
Atrys Health is a healthcare company that focuses on medical diagnosis, cancer treatment, and remote medical services. It helps hospitals, clinics, and patients with tests and clinical services such as imaging, pathology, lab diagnostics, and telemedicine. In simple terms, it sits between the doctor and the patient by supplying the specialist tools and medical expertise needed to detect disease and guide treatment.
- Headquarters
- Spain ES
- Employees
- 656
- IPO date
- Jul 22, 2016
Earnings Waterfall
Atrys Health SA
The intrinsic value for Atrys Health SA (A2T) under the Base Case is hidden EUR.
Compared with the current market price of 2.54 EUR, the stock appears hidden.